Benjamin Maynor
26Patents
6h-index
16Co-inventors
62Inventor score
Filing activity: Dec 20, 2004 → Jul 12, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8263129B2 | Methods for fabricating isolated micro-and nano-structures using soft or imprint lithography | Emerging Cross-Sectional Technologies | 41 | Active |
| US8128393B2 | Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom | Emerging Cross-Sectional Technologies | 25 | Active |
| US8420124B2 | Methods for fabricating isolated micro- and nano-structures using soft or imprint lithography | Emerging Cross-Sectional Technologies | 15 | Active |
| US7976759B2 | System and method for producing particles and patterned films | Emerging Cross-Sectional Technologies | 11 | Active |
| US8439666B2 | Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom | Emerging Cross-Sectional Technologies | 8 | Active |
| US8518316B2 | System and method for producing particles and patterned films | Emerging Cross-Sectional Technologies | 6 | Active |
| US8662878B2 | Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom | Emerging Cross-Sectional Technologies | 6 | Active |
| US10898494B2 | Dry powder treprostinil for the treatment of pulmonary hypertension | Human Necessities | 5 | Active |
| US9040090B2 | Isolated and fixed micro and nano structures and methods thereof | Emerging Cross-Sectional Technologies | 5 | Active |
| US9902818B2 | Isolated and fixed micro and nano structures and methods thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US8685461B2 | Nanoparticle fabrication methods, systems, and materials | Human Necessities | 2 | Active |
| US9340001B2 | Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom | Emerging Cross-Sectional Technologies | 2 | Active |
| US8945441B2 | Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom | Emerging Cross-Sectional Technologies | 2 | Active |
| US8992992B2 | Methods for fabricating isolated micro- or nano-structures using soft or imprint lithography | Emerging Cross-Sectional Technologies | 2 | Active |
| US9877920B2 | Methods for fabricating isolated micro- or nano-structures using soft or imprint lithography | Emerging Cross-Sectional Technologies | 1 | Active |
| US9545737B2 | System and method for producing particles and patterned films | Emerging Cross-Sectional Technologies | 1 | Active |
| US10842748B2 | Methods for fabricating isolated micro- or nano-structures using soft or imprint lithography | Emerging Cross-Sectional Technologies | 1 | Active |
| US10517824B2 | Methods for fabricating isolated micro- or nano-structures using soft or imprint lithography | Emerging Cross-Sectional Technologies | 1 | Active |
| US11712442B2 | Dry powder treprostinil for the treatment of pulmonary hypertension | Human Necessities | 0 | Active |
| US10717209B2 | Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom | Emerging Cross-Sectional Technologies | 0 | Active |
| US11660304B2 | Dry powder treprostinil for the treatment of pulmonary hypertension | Human Necessities | 0 | Active |
| US12390475B2 | Dry powder treprostinil for the treatment of pulmonary hypertension | Human Necessities | 0 | Active |
| US9662809B2 | Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom | Emerging Cross-Sectional Technologies | 0 | Active |
| US11744836B2 | Dry powder treprostinil for the treatment of pulmonary hypertension | Human Necessities | 0 | Active |
| US11642313B2 | Methods for fabricating isolated micro- or nano-structures using soft or imprint lithography | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.